Ron Finn

589 total citations
7 papers, 445 citations indexed

About

Ron Finn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ron Finn has authored 7 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ron Finn's work include Radiopharmaceutical Chemistry and Applications (3 papers), Medical Imaging Techniques and Applications (2 papers) and Hormonal and reproductive studies (1 paper). Ron Finn is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Medical Imaging Techniques and Applications (2 papers) and Hormonal and reproductive studies (1 paper). Ron Finn collaborates with scholars based in United States, Brazil and Netherlands. Ron Finn's co-authors include Steven M. Larson, John L. Humm, Joseph A. O’Donoghue, Olivia Squire, Maria J.W.D. Vosjan, Marijke Stigter‐van Walsum, Gerard W.M. Visser, Julliëtte E M van Eerd, Ronald Boellaard and Otto C. Boerman and has published in prestigious journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging and Cancer Biotherapy and Radiopharmaceuticals.

In The Last Decade

Ron Finn

7 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Finn United States 7 274 168 116 111 77 7 445
Johan Spetz Sweden 13 223 0.8× 90 0.5× 146 1.3× 133 1.2× 70 0.9× 34 508
Linda Lam United States 8 113 0.4× 202 1.2× 203 1.8× 131 1.2× 79 1.0× 23 467
John Bernard France 5 129 0.5× 363 2.2× 87 0.8× 135 1.2× 135 1.8× 8 472
Vincent A. DiPippo United States 12 210 0.8× 199 1.2× 104 0.9× 131 1.2× 137 1.8× 29 552
C. M. Schlotter Germany 8 89 0.3× 57 0.3× 145 1.3× 194 1.7× 83 1.1× 22 329
Donna J. Affleck United States 15 369 1.3× 75 0.4× 127 1.1× 141 1.3× 84 1.1× 29 542
A. Barnadas Spain 10 84 0.3× 88 0.5× 179 1.5× 244 2.2× 83 1.1× 27 419
Eri Taguchi Japan 7 83 0.3× 95 0.6× 219 1.9× 119 1.1× 79 1.0× 11 367
Masako Uno Japan 12 130 0.5× 87 0.5× 180 1.6× 148 1.3× 57 0.7× 38 528
Victoria Rimkunas United States 10 80 0.3× 225 1.3× 276 2.4× 272 2.5× 108 1.4× 26 556

Countries citing papers authored by Ron Finn

Since Specialization
Citations

This map shows the geographic impact of Ron Finn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Finn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Finn more than expected).

Fields of papers citing papers by Ron Finn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Finn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Finn. The network helps show where Ron Finn may publish in the future.

Co-authorship network of co-authors of Ron Finn

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Finn. A scholar is included among the top collaborators of Ron Finn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Finn. Ron Finn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Beattie, Bradley J., Peter Smith‐Jones, Yuliya Jhanwar, et al.. (2010). Pharmacokinetic Assessment of the Uptake of 16β-18F-Fluoro-5α-Dihydrotestosterone (FDHT) in Prostate Tumors as Measured by PET. Journal of Nuclear Medicine. 51(2). 183–192. 89 indexed citations
2.
Wen, Bixiu, Paul Burgman, Pat Zanzonico, et al.. (2004). A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia. European Journal of Nuclear Medicine and Molecular Imaging. 31(11). 1530–1538. 44 indexed citations
3.
Divgi, Chaitanya, Joseph A. O’Donoghue, Sydney Welt, et al.. (2004). Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer.. PubMed. 45(8). 1412–21. 66 indexed citations
4.
Verel, Iris, Gerard W.M. Visser, Otto C. Boerman, et al.. (2003). Long-Lived Positron Emitters Zirconium-89 and Iodine-124 for Scouting of Therapeutic Radioimmunoconjugates with PET. Cancer Biotherapy and Radiopharmaceuticals. 18(4). 655–661. 110 indexed citations
5.
Russell, James, Joseph A. O’Donoghue, Ron Finn, et al.. (2002). Iodination of annexin V for imaging apoptosis.. PubMed. 43(5). 671–7. 40 indexed citations
6.
Kramer, Kim, Nai‐Kong V. Cheung, John L. Humm, et al.. (2000). Targeted radioimmunotherapy for leptomeningeal cancer using131I-3F8. Medical and Pediatric Oncology. 35(6). 716–718. 31 indexed citations
7.
Levchenko, Andre, Jongbin Lee, John L. Humm, et al.. (2000). Evaluation of 11C-colchicine for PET imaging of multiple drug resistance.. PubMed. 41(3). 493–501. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026